Inkeri Elomaa

9.9k citations
145 papers · 6.7k indexed · 1 hit paper · h-index 46

Impact in

Papers in

Inkeri Elomaa

142 papers receiving 6.4k citations

Hit Papers

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation 1993 · 549 citations
5491993202620042015100200300400500

Peers

Inkeri Elomaa
Comparison fields: 5 of 116
  • Oncology 3.8k
  • Orthopedics and Sports Medicine 1.0k
  • Pulmonary and Respiratory Medicine 2.5k
  • Cancer Research 960
  • Rheumatology 729
Replace Saroj Vadhan‐Raj with:
Saroj Vadhan‐Raj United States
G. Bastert Germany
Diana Julie Leeming Denmark
Fabio Falcini Italy
David H. Henry United States
Giuseppe Avvisati Italy
Klaus Lechner Austria
Paul S. Ritch United States
Norbert Ifrah France
Ashraf Badros United States
Inkeri Elomaa relative to Saroj Vadhan‐Raj United States Saroj Vadhan‐Raj's profile →
Citations per field
00.5×3.3×
Saroj Vadhan‐Raj · 1×
Citations per year

Countries citing papers authored by Inkeri Elomaa

Since Specialization
Citations

This map shows the geographic impact of Inkeri Elomaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inkeri Elomaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inkeri Elomaa more than expected).

Fields of papers citing papers by Inkeri Elomaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inkeri Elomaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inkeri Elomaa. The network helps show where Inkeri Elomaa may publish in the future.

Co-authors

The 25 scholars most cited alongside Inkeri Elomaa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Inkeri Elomaa Line = papers co-authored together Inkeri Elomaa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201322
2 20018
3 200081
4 200052
5 199924
6 199933
7 199795
8 199654
9 19966
10 199535
11 199580
12 199421
13 19934
14 199344
15 199217
16 1992130
17 199257
18 1992300
19 19885
20
Hypercalcemia and elevated serum parathyroid hormone level in association with rhabdomyosarcoma.
198411

About Inkeri Elomaa

Inkeri Elomaa is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Orthopedics and Sports Medicine, Cancer Research and Rheumatology, having authored 145 papers that have together received 6.7k indexed citations. Recurring topics across this work include Bone health and treatments (51 papers), Sarcoma Diagnosis and Treatment (45 papers), Radiopharmaceutical Chemistry and Applications (17 papers), Cancer Treatment and Pharmacology (15 papers), Bone Tumor Diagnosis and Treatments (14 papers), Bone health and osteoporosis research (14 papers), Cancer Genomics and Diagnostics (13 papers) and Multiple Myeloma Research and Treatments (11 papers). The work is most often cited by research in Oncology (3.8k citations), Orthopedics and Sports Medicine (1.0k citations), Pulmonary and Respiratory Medicine (2.5k citations), Cancer Research (960 citations) and Rheumatology (729 citations). Inkeri Elomaa has collaborated with scholars based in Finland, Sweden and Norway. Frequent co-authors include Carl Blomqvist, Tiina Saarto, Juha Risteli, Leila Risteli, Pekka Virkkunen, Maija Tarkkanen, Leena Vehmanen, S. Niemi, Sakari Knuutila and Tom Wiklund. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Journal of Clinical Oncology, Acta Oncologica and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026